Fingerprint
Dive into the research topics where Pim Damen is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Pretreatment risk model for radiation-induced lymphopenia is associated with adjuvant durvalumab efficacy in patients with unresectable stage III NSCLC
van Rossum, P. S. N., Damen, P. J. J., Cortiula, F., Hobbs, B. P., De Marchi, L., Mohan, R., Peters, M., Schneiders, F. L., De Ruysscher, D., Wijsman, R., Verhoeff, J. J. C., Xu, T., Liao, Z. & Lin, S. H., 26 Feb 2026, (E-pub ahead of print) In: International journal of radiation oncology, biology, physics.Research output: Contribution to journal › Article › Academic › peer-review
Open Access -
Efficacy of stereotactic ablative radiotherapy (SABR) during anti-PD-1 in oligoprogressive non-small cell lung cancer and melanoma—a prospective multicenter observational study pointing out new unmet needs
Damen, P. J. J. & Verhoeff, J. J. C., 2023, In: TRANSLATIONAL CANCER RESEARCH. 12, 3, p. 688-691 4 p.Research output: Contribution to journal › Comment/Letter to the editor › Academic
Open AccessFile28 Downloads (Pure)